Clinical Utility of ERCP Guided Cholangiopancreatoscopy With the SpyGlass DS
| Status: | Recruiting |
|---|---|
| Conditions: | Gastrointestinal |
| Therapuetic Areas: | Gastroenterology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 4/21/2016 |
| Start Date: | August 2015 |
| End Date: | June 2020 |
| Contact: | Peter V Draganov, MD |
| Email: | dragapv@medicine.ufl.edu |
| Phone: | 352-273-9474 |
Prospective Evaluation of the Clinical Utility of Endoscopic Retrograde Cholangiopancreatography (ERCP) Guided Cholangiopancreatoscopy With the SpyGlass DS.
This is a prospective evaluation of the clinical utility of the new cholangioscopy platform
SpyGlass DS. The aims of this study are to prospectively document the clinical utility and
technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and
management of pancreata-biliary disorders.
SpyGlass DS. The aims of this study are to prospectively document the clinical utility and
technical aspects of ERCP with cholangioscopy and/or pancreatoscopy in the diagnosis and
management of pancreata-biliary disorders.
Cholangioscopy allows for direct visualization of the bile and pancreatic duct. In 2006, the
SpyGlass Direct Visualization System for per-oral cholangiopancreatoscopy was introduced and
since then has been shown to provide incremental diagnostic and therapeutic benefits. The
main limitations of the original SpyGlass platform are fiberoptic visualization system,
limited tip angulation, square cut Spy scope tip, and complex multicomponent setup. A new
generation cholangioscopy platform, SpyGlass DS is currently in clinical use. The new system
addresses many of the shortcomings of old platform including digital optics, improved tip
angulation, tapered tip and simplified set up. It is unclear at this time wether this
technical improvement will translate into better outcomes. Therefore, the investigators want
to study the clinical utility of SpyGlass DS by prospectively collecting data on the
clinical outcomes of patients undergoing cholangioscopy with Spyglass DS as part of their
routine medical care.
SpyGlass Direct Visualization System for per-oral cholangiopancreatoscopy was introduced and
since then has been shown to provide incremental diagnostic and therapeutic benefits. The
main limitations of the original SpyGlass platform are fiberoptic visualization system,
limited tip angulation, square cut Spy scope tip, and complex multicomponent setup. A new
generation cholangioscopy platform, SpyGlass DS is currently in clinical use. The new system
addresses many of the shortcomings of old platform including digital optics, improved tip
angulation, tapered tip and simplified set up. It is unclear at this time wether this
technical improvement will translate into better outcomes. Therefore, the investigators want
to study the clinical utility of SpyGlass DS by prospectively collecting data on the
clinical outcomes of patients undergoing cholangioscopy with Spyglass DS as part of their
routine medical care.
Inclusion Criteria:
- Participants who have been scheduled to undergo a cholangiopancreatoscopy as routine
clinical care
Exclusion Criteria:
- failure to provide informed consent
- any contraindications to endoscopy
We found this trial at
1
site
Gainesville, Florida 32610
Principal Investigator: Peter V Draganov, MD
Phone: 352-273-9400
Click here to add this to my saved trials
